Logo for FT News podcast

Doctors in the US are wasting hundreds of millions of dollars a year prescribing expensive branded medicines even when cheaper generic alternatives are available, according to an FT analysis. David Crow and Sujeet Indap discuss the findings.

Get alerts on when a new story is published

Copyright The Financial Times Limited 2018. All rights reserved.

Comments have not been enabled for this podcast.

Follow the topics in this podcast